Navigation Links
Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom

ores declined 56% (24.2 points) from baseline for children treated with DAYTRANA versus a decline of 24% (10.3 points) for those treated with placebo (P < .0001). ADHD-RS-IV assesses 18 individual symptoms of ADHD as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision?, a publication of the American Psychiatric Association.

In both the phase II and phase III studies, DAYTRANA was generally well tolerated during both the dose optimization and double-blind phases. Adverse events typically were mild to moderate, resolved with continued therapy and were consistent with known effects of methylphenidate.

Important Safety Information

DAYTRANA was generally well tolerated in clinical studies. As with other products containing methylphenidate (the active ingredient in DAYTRANA), common side effects reported with DAYTRANA were decreased appetite, insomnia, nausea, vomiting, weight loss, tics, and affect lability (mood swings). Abuse of methylphenidate may lead to dependence.

Parents or caregivers should tell the child's physician about any heart conditions their child or family members may have. Also parents and caregivers should tell the doctor if their child has a history of high blood pressure, problems with alcohol or drugs, depression, bipolar disorder, abnormal thoughts/behaviors, visual disturbances, or seizures. Inform the doctor immediately if the child develops symptoms that suggest heart problems, such as chest pain or fainting. Aggression, new abnormal thoughts/behaviors, mania, and growth suppression have been associated with use of drugs of this type. Methylphenidate should not be taken by children with significant agitation; glaucoma; tics, family history or diagnosis of Tourette's syndrome; or current/recent use of MAO inhibitors (a type of antidepressant). DAYTRANA should not be used by children allergic to methylphenidate or other ingredients in DAYTRANA.

DAYTRA
'"/>




Page: 1 2 3 4

Related medicine news :

1. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
2. The Lachlan Shire Council To Fund GP For Condobolin Health Service
3. Poor Health of people in Central Goldfields Shire, reports The Victorian Burden of Disease
4. Scientists Developed Map For Brain Molecular Communities
5. Scientists Developed Cheap Way To Assess Sleep
6. Diabetic Friendly Egg Developed In India
7. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
8. Cervical Cancer Vaccine To Be Developed In India
9. Anti-Microbial Coating For Use Over Biomedical Devices Developed
10. Cure for Osteoarthritis To Be Developed
11. Mice With Human Thought Processes Could Be Developed In The Future
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Shire Developed DAYTRANA The First Medication Treat ADHD Symptom

(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom ... cardiology is the identification of individuals with active yet undetected sub-clinical disease, who ...
(Date:7/28/2015)... ... July 28, 2015 , ... Coco Libre announced today ... Award for the Nutrition Beverage category. Established by NCW Magazine, the Awards recognize ... stand out for their social and environmental sustainability. , “This award is great ...
(Date:7/28/2015)... ... ... PeopleKeys today announced that their partner, Celtic Healthcare CEO ... the Year award. The award recognizes the important strides Burchianti and Celtic Healthcare ... have done in incorporating new technology, processes, and procedures into their homecare, hospice, ...
(Date:7/28/2015)... ... July 28, 2015 , ... VAZATA, a ... expanding their cloud presence to support their rapidly growing business. , Headquarted in ... been serving the Dallas/Fort Worth area for almost 50 years. HeartPlace is recognized ...
(Date:7/28/2015)... ... ... the 5th Annual Step for Hope 5K Run/Walk on Saturday, September 12, 2015 ... Stream. All are welcome. , Now in its 5th year, the Step for Hope ... families affected by a brain aneurysm. , “We look forward to you joining us ...
Breaking Medicine News(10 mins):Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Coco Libre Wins 2015 NCW Eco-Excellence Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:HeartPlace Announces Cloud Expansion with VAZATA 2Health News:HeartPlace Announces Cloud Expansion with VAZATA 3Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2
... 5 The following is a statement by ... commends Reps. Bart Stupak (D-Mich.) and Candice Miller ... (H.R. 903), a bill that would bolster America,s ... attacks by taking advantage of the extensive education, ...
... U.S. Conference of Catholic Bishops (USCCB) has launched ... widely-supported pro-life policies and to oppose the federal ... 24-25, the campaign is being coordinated through the ... Human Life Amendment (NCHLA).To date, tens of millions ...
... Cold Spring Harbor, N.Y. Before a cell can divide ... packed in its chromosomes. The two new sets of chromosomes ... distributed to the resulting "daughter" cells, so that both daughter ... , During cell division, a cellular organ called the ...
... Tenn., Feb. 5 /PRNewswire/ -- As the ... healthcare industry, Quorum Health Resources (QHR) has announced the ... owned QHR subsidiary that provides hospitals and health systems ... face. The challenges are great, according to the American ...
... able to compete globally in tomorrow,s economy, and may ... result of the recent federal budget, states an editorial ... . Health researchers and clinicians, institutions and others must ... of the many medical and scientific advancements discovered in ...
... Directors of,Hawkins, Inc. (Nasdaq: HWKN ), at its ... $0.26 per share payable April 3, 2009, to,shareholders of record ... This is,the 24th consecutive year the Company has paid cash ... Hawkins, Inc. provides a full range ...
Cached Medicine News:Health News:Statement by ADA President John S. Findley on the Dental Emergency Responder Act Introduced Today by Reps. Stupak and Miller 2Health News:Massive Nationwide Pro-Life Postcard Campaign Underway 2Health News:CSHL scientists discover link between control of chromosome duplication and segregation 2Health News:CSHL scientists discover link between control of chromosome duplication and segregation 3Health News:Intensive Resource Group (IRG) Helps Hospitals Address Financial and Operational Crisis 2Health News:Intensive Resource Group (IRG) Helps Hospitals Address Financial and Operational Crisis 3
(Date:7/28/2015)... , July 28, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Human Insulin Market Development ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore more ...
(Date:7/28/2015)... LINCOLNSHIRE, Ill. , July 28, 2015 ... acumen on par with their levels of clinical excellence. ... (AACC) Annual Meeting & Clinical Lab Expo, Sysmex is ... deliver a comprehensive and intuitive ecosystem that will help ... four key areas, Sysmex aims to add even more ...
(Date:7/28/2015)... July 28, 2015 Rigel Pharmaceuticals, Inc. (Nasdaq: ... report its second quarter 2015 financial results after market ... management will follow the announcement with a live ... (1:30pm Pacific Time) to discuss the financial results. ... call by dialing 855-892-1489 (domestic) or 720-634-2939 (international) ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2
Therapeutic Drug Calibrator Series...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma...
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Medicine Products: